Michelle Chen

Dr. Chen is a biotech entrepreneur & executive with extensive experience and successful track record in corporate development, R&D and commercialization. Currently she is an executive director of business development at Merck. Prior to that she served as the head of corporate development of several biotech companies and helped them with fund raising, partnerships, product development strategy, press release and investor relationship.

Dr. Chen started her biotech career in R&D at Scios (now Johnson & Johnson) and later Abgenix (now Amgen) as a group leader. She then went on to gain marketing and business development experience at global companies such as Agilent, Roche Dx and Roche Pharma where she was responsible for global business development licensing, collaborations, M&A and external pharma partnerships in personalized medicine, Dx and drug development deals.

Dr. Chen obtained a PhD in Biochemistry from the University of Washington, followed by the post-doctoral work at UCSF.  In addition she received bioinformatics training at Stanford University.